Reports for SANDOZ CANADA INCORPORATED

Company Name

SANDOZ CANADA INCORPORATED

Totals

Shortage reports

1841

Actual shortage: 45 (2%)
Anticipated shortage: 1 (0%)
Avoided shortage: 13 (1%)
Resolved: 1782 (97%)

Discontinuation Reports

82

To be discontinued: 1 (1%)
Discontinued: 79 (96%)
Reversed: 2 (2%)

Late reports

439 (23%)

Overdue reports

1 (2%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SANDOZ VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Resolved 2019-02-04 2019-02-13 74737
SANDOZ VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Resolved 2019-02-18 2019-03-13 76169
SANDOZ VENLAFAXINE XR 150.0MG CAPSULE (EXTENDED RELEASE) Resolved 2019-05-07 2020-01-22 83298
SANDOZ VENLAFAXINE XR 150.0MG CAPSULE (EXTENDED RELEASE) Resolved 2019-05-07 2020-01-22 83301
SANDOZ VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2019-06-12 2020-01-22 86402
SANDOZ VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Resolved 2019-10-15 2020-01-22 96540
SANDOZ VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Resolved 2019-10-15 2020-01-22 96547
VERAPAMIL HYDROCHLORIDE INJECTION USP 2.5MG LIQUID Resolved 2023-11-06 2024-01-03 209230
VERAPAMIL HYDROCHLORIDE INJECTION USP 2.5MG LIQUID Resolved 2022-11-28 2023-01-19 175970
VERAPAMIL HYDROCHLORIDE INJECTION USP 2.5MG LIQUID Resolved 2023-03-03 2023-04-22 186176
VERAPAMIL HYDROCHLORIDE INJECTION USP 2.5MG LIQUID Resolved 2023-07-10 2023-08-01 198005
VISTITAN 0.03% SOLUTION Resolved 2021-09-13 2021-10-04 145576
VISTITAN 0.03% SOLUTION Resolved 2022-02-01 2022-03-25 154002
VISTITAN 0.03% SOLUTION Resolved 2022-06-29 2022-07-07 163618
VISTITAN 0.03% SOLUTION Resolved 2023-04-11 2023-04-22 189229
VISTITAN 0.03% SOLUTION Actual shortage 2024-03-05 2024-04-16 221377
VITAMIN B1 100MG SOLUTION Actual shortage 2024-02-15 2024-05-29 219763
VITAMIN B12 1000MCG SOLUTION Resolved 2022-03-03 2022-03-25 155930
VITAMIN B12 1000MCG SOLUTION Resolved 2022-10-04 2022-10-20 171057
VITAMIN B12 1000MCG SOLUTION Resolved 2022-10-26 2022-11-16 172698

Showing 1801 to 1820 of 1841

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
FOLIC ACID INJECTION USP 5MG LIQUID To be discontinued 2019-05-01 2019-05-01 82956
FOLIC ACID INJECTION USP 5MG LIQUID Discontinued 2020-01-28 2020-01-28 104481
SANDOZ ALENDRONATE 10MG TABLET Discontinued 2019-11-19 2019-11-19 99259
ALFENTANIL INJECTION USP Discontinued 2019-10-15 2019-10-15 96610
ATRACURIUM BESYLATE INJECTION Discontinued 2019-10-15 2019-10-15 96613
SODIUM AUROTHIOMALATE INJECTION BP 50MG SOLUTION Discontinued 2018-07-13 2018-07-13 55768
BETAJECT Discontinued 2019-10-15 2019-10-15 96616
BLUE COLLYRIUM Discontinued 2019-10-15 2019-10-15 96619
BRETYLIUM TOSYLATE INJECTION USP 50MG SOLUTION Discontinued 2017-12-06 2017-12-06 31958
BRETYLIUM TOSYLATE INJECTION USP Discontinued 2020-04-01 2020-04-01 110288
CLINDAMYCIN INJECTION USP 150MG LIQUID Discontinued 2017-06-06 2017-10-18 12122
CODEINE PHOSPHATE INJECTION USP 30MG LIQUID Discontinued 2022-04-20 2022-04-20 159064
COMTAN 200MG TABLET Discontinued 2022-03-03 2022-03-04 155940
SANDOZ DILTIAZEM T Discontinued 2020-04-01 2020-04-01 110324
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Discontinued 2018-08-27 2019-01-02 59179
SANDOZ FINASTERIDE A 1MG TABLET Discontinued 2023-06-30 2023-07-01 196983
HEPARIN SODIUM INJECTION USP (SINGLE USE VIAL-PRESERVATIVE FREE) 10000UNIT SOLUTION Discontinued 2018-07-04 2018-07-31 54349
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2023-10-18 2023-10-19 207275
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2024-05-17 2024-05-18 228249
IMIPENEM AND CILASTATIN FOR INJECTION USP 250MG 250MG POWDER FOR SOLUTION Discontinued 2021-08-23 2021-08-23 144467

Showing 1 to 20 of 82